4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-014326
Matsuda Masaru sold 12,058 shares at an average $26.03 ($313,877)
- Matsuda Masaru acquired 37,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-27 | Grant or award : show line 1 in the form 10b5-1 | +37,000 | 147,003 | D | ||
| 2026-02-27 | Sale : show line 2 in the form 10b5-1 | −3,325 | $27.95 | $92,934 | 143,678 | D |
| 2026-03-02 | Sale : show line 3 in the form 10b5-1 | −6,553 | $25.16 | $164,876 | 137,125 | D |
| 2026-03-02 | Sale : show line 4 in the form 10b5-1 | −193 | $25.91 | $5,001 | 136,932 | D |
| 2026-03-02 | Sale : show line 5 in the form 10b5-1 | −1,987 | $25.70 | $51,066 | 136,932 | D |
| Open-market sales · 12,058 sh · avg $26.03 · $313,877 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-27 | Grant or award : show line 6 in the form 10b5-1 Stock Option (right to buy) | +97,000 | 97,000 | D |
Loading xslF345X05/wk-form4_1772588538.xml…